Medi-Physics, Inc.

Medi-Physics, Inc., operating as GE Healthcare, manufactures and supplies radiopharmaceuticals and diagnostic imaging agents to the Department of Veterans Affairs, Defense Health Agency, and Navy as a prime contractor operating without small business set-aside designation. A subsidiary of General Electric Company headquartered in Marlborough, Massachusetts, Medi-Physics is a large for-profit manufacturer competing exclusively in full-and-open procurements, with a federal footprint dominated by delivery orders and blanket purchase agreement calls under the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB).

Medi-Physics' capability portfolio centers on nuclear medicine radiopharmaceuticals: DATSCAN (ioflupane I-123) for single-photon emission computed tomography imaging of neurological conditions such as Parkinson's disease; VIZAMYL (flutemetamol F-18 injection) for positron emission tomography procedures; and FLYRCADO (flurpiridaz F-18 injection) for advanced molecular imaging. Recent representative work includes a $2.53 million delivery order from VA VISN 5 for VIZAMYL and DATSCAN through December 31, 2030; a $1.85 million delivery order from VA VISN 16 for radiopharmaceuticals through November 30, 2024; and a $1.649 million definitive contract from VA VISN 22 for supplemental radiopharmaceuticals (DATSCAN and VIZAMYL) with performance through April 30, 2029. The company also holds a $950 thousand Defense Health Agency blanket purchase agreement for imaging reagents and diagnostic imaging agents through September 23, 2030, with individual task orders historically ranging from approximately $8 thousand to $276 thousand.

Customer concentration skews sharply toward the Department of Veterans Affairs across regional networks, with VA VISN 12 anchoring 66% of combined potential value across the vendor's portfolio—31 awards valued at $54.6 million. The next four customer rankings by potential value are VA VISN 22 (80 awards, $16.1 million), Defense Health Agency (23 awards, $13.6 million), VA VISN 21 (32 awards, $10.6 million), and VA VISN 8 (32 awards, $10.4 million). A divergence exists between award count and dollar concentration: VA VISN 22 places the most individual orders (80 awards) but ranks second by dollars; VA VISN 12 places fewer orders (31) but dominates potential value. Navy Bureau of Medicine and Surgery accounts for 64 awards valued at $2.7 million—a distant third in order volume but a meaningful operational customer. The top five customer agencies (by potential value) account for 66% of all awards.

Medi-Physics operates under multiple parent vehicles. The GSA Federal Supply Schedule V797P5854X carries 1,023 task orders valued at $5.9 million combined potential value—a baseline supply mechanism. The Pharmaceuticals and Drugs FSS-61-IB parent vehicle underpins 168 task orders valued at $32.7 million. Additionally, the vendor holds single-award blanket purchase agreements with VA VISN 8 (ceiling $2.01 million through February 28, 2027), VA VISN 15 (ceiling $1.39 million through January 15, 2030), VA VISN 12 (ceiling $1.046 million through March 31, 2026), Defense Health Agency (ceiling $950 thousand through September 23, 2030), and an indefinite delivery contract with VA VISN 17 for FLYRCADO (ceiling $1.289 million through March 7, 2031). These IDVs serve as the scaffolding for individual task orders; the VISN 8 BPA alone supported call orders totaling approximately $855 thousand across multiple annual cycles.

Activity has remained flat to slightly declining across the past five years—25 awards in 2022, 22 in 2023, 29 in 2024, 27 in 2025, and 19 in the first eight months of 2026. Within the next twenty-four months, 28 awards (combined potential value $4.2 million) reach ultimate completion, creating recompete exposure. The most recent award is dated August 1, 2026 (a $27,788 delivery order from VA VISN 23 for DATSCAN imaging supply).

Medi-Physics' federal footprint is entirely prime; the source reports zero subcontract activity. The company's NAICS profile is dominated by 1,402 awards under code 325412 (Pharmaceutical Preparation Manufacturing), with smaller volume under codes 424210 (Drugs and Druggists' Sundries Merchant Wholesalers), 339113 (Surgical Appliance and Supplies Manufacturing), and miscellaneous repair. By PSC code, Drugs and Biologicals (612 awards) and Medical and Surgical Instruments, Equipment, and Supplies (442 awards) dominate; In Vitro Diagnostic Substances and Reagents (298 awards) and Imaging Equipment and Supplies (138 awards) round out the operational mix.

General Electric Company, the parent, is a large for-profit conglomerate with its own substantial federal contracting presence across defense, energy, healthcare, and civilian IT sectors. Medi-Physics operates as a specialized subsidiary focused exclusively on radiopharmaceutical manufacture and supply to federal healthcare networks, with no diversification into adjacent healthcare products or services within the visible award footprint.